Peter J. Hulick, MD, MMSc
Peter J. Hulick is the Division Head and a medical geneticist at the NorthShore University HealthSystem Center for Medical Genetics and an Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine.
Dr. Hulick completed his clinical medical genetics residency at Harvard Medical School where his clinical concentrations included connective tissue diseases such as Marfan syndrome and Ehlers-Danlos syndrome while also maintaining a general genetics clinic.
His research during his Harvard genetics training consisted of identifying potential biomarkers of kidney cancer through gene expression profiling of tumor cell lines and the development of a clinical assay to detect kidney cancer at an early stage. He also studied the biological function of the folliculin gene product which, when mutated, causes the kidney cancer predisposition syndrome Birt-Hogg-Dube. During his medical genetics residency, he graduated with a masters in medical science degree from the Harvard Medical Scholars in Clinical Science program which trains individuals for careers in clinical research.
Dr. Hulick received his undergraduate degree in biology from Northwestern University in Evanston, IL and his medical degree from Jefferson Medical College, in Philadelphia, PA. He completed an internal medicine residency at Mayo Clinic, Jacksonville, FL before pursuing his clinical medical genetics training in Boston. Dr. Hulick is board certified in Internal Medicine and Clinical Genetics.
His clinical interests, in addition to general genetic syndromes, include connective tissue disease, cardiovascular, and kidney cancer genetics.
Shashanna Ndong, MD
Shashanna Ndong is a medical geneticist at the NorthShore University HealthSystem Center for Medical Genetics and a Clinical Educator at the University of Chicago School of Medicine.
Dr. Ndong completed her medical genetics training at the Icahn School of Medicine at Mount Sinai Medical Center in New York City. Her research included analysis of the effect of variants of uncertain significance in BRCA1 and BRCA2 on patient management decisions. She also participated in a retrospective analysis of the ophthalmologic findings in individuals with Fabry disease and studied the natural history of recurrent copy number variants. She completed residency at the University of Illinois at Chicago and is board certified in Medical Genetics, Internal Medicine, and Pediatrics.
Her professional interests include congenital hearing loss, cardiovascular genetic disorders, and neurogenetic disorders in both adult and pediatric populations.
Henry T. Lynch, MD
Henry T. Lynch is the Medical Advisor of the NorthShore Center for Medical Genetics.
He is Professor and Chairman of the Department of Preventive Medicine, Professor of Medicine, and the Director of the Creighton Cancer Center at Creighton University in Omaha, Nebraska. Dr. Lynch earned his MD at the University of Texas and trained in the internal medicine residency program at the University of Nebraska Medical Center.
Regarded by many as the father of cancer genetics, Dr. Lynch spent the majority of his career researching the hereditary basis of cancer and has published over 600 articles. He was the first to bring Hereditary Non-Polyposis Colorectal Cancer syndrome to general attention; the syndrome also bears his name as Lynch Syndrome. He has won numerous awards including the American Cancer Society Distinguished Service Award in 1992, the Sixth AACR (American Association for Cancer Research) American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention in 1997, the American Cancer Society 1997 Medal of Honor Clinical Research Award, The Susan G. Komen Breast Cancer Foundation 1998 Brinker International Award for Breast Cancer Clinical Research, the 2000 American Cancer Society Lecture Award given by the American Society of Clinical Oncology, and the Lifetime Achievement Award in Inherited Pancreatic Diseases awarded by The International Association of Pancreatology in 2001. Dr. Lynch has traveled the world, spreading knowledge of hereditary cancer and stimulating research investigations, and has mentored a generation of physicians and scientists in this field.
Nicole Hook, MS, CGC
Nicole Hook earned her Master of Science degree in Genetic Counseling from Northwestern University, following completion of her Bachelor’s degree in Biotechnology at the Rochester Institute of Technology. Throughout her training, Nicole gained experience in patient care and genetics research. She provided genetic counseling for patients within a broad range of clinical specialties, including prenatal, pediatric and cancer genetics. She was also involved with a research project exploring the molecular mechanisms of polycystic kidney disease, and participated in a task force which created an online module designed to explain alcohol’s effects to domestic violence perpetrators.
Nicole has a particular interest in neuromuscular disorders and completed her thesis work studying parental decision making about disclosure of disease-related information to children with Duchenne Muscular Dystrophy. She also enjoys providing risk assessment and support for adult patients facing personal and family histories of cancer.
Catherine Long, MS, CGC
Cathy Long is a licensed and board-certified genetic counselor who earned her M.S. in Genetic Counseling from the University of Colorado-Denver and her B.A. in Biological Sciences from the University of Chicago. Cathy’s strong clinical experience includes providing genetic counseling in a high-volume, mixed general and metabolic genetics clinic in a pediatric setting, and serving as the clinical coordinator in dual-disciplinary neurogenetics and neurometabolics clinics.
She has served as an assistant research coordinator for various clinical research trials. She also has an extensive background in basic science research, particularly in the areas of immunology and apoptosis. As a graduate student, Cathy helped to create a set of internationally distributed patient visual aids for inherited metabolic disorders. Her professional interests also include working with families to provide genetic counseling and risk assessment for a variety of adult-onset genetic conditions, often times involving a personal or family history of cancer.
Anna Newlin, MS, CGC
Anna Newlin, MS, CGC, is a board certified genetic counselor who earned her Master of Science degree in Human Genetics from the University of Michigan, Ann Arbor where she trained under the tutelage of several well known clinical and research geneticists, including Dr. Francis Collins, who currently heads the Human Genome Project. Anna has a broad base of clinical experience which includes prenatal as well as pediatric genetic counseling. Anna spent several years involved in clinical ophthalmic genetics which provided her with the unique opportunity to work with families with hereditary eye disorders. Her interests have shifted to providing risk assessment to adult patients, the majority of whom are referred for a personal or family history of cancer.
Holly May, MS, CGC
Holley May received a Master of Science degree in Genetic Counseling from Northwestern University and a Bachelor of Science degree in Molecular & Cellular Biology at the University of Arizona. As a part of her training, Holley provided genetic counseling to patients in a variety of clinical settings including prenatal, pediatric and cancer genetics. Following completion of her graduate studies, Holley worked as a prenatal counselor providing genetic counseling to pregnant women and their families. She also previously worked as a laboratory research assistant working to improve targeted drug therapies for cancer. Holley enjoys working to provide risk assessment and genetic counseling to adults at risk for various adult-onset genetic conditions, including personal and family histories of cancer.
Christina Selkirk, MS
Christina Selkirk earned her Bachelors Degree from Skidmore College in 2001. She spent the next several years conducting research relevant to women’s reproductive health issues in an ovarian physiology lab under the direction of Dr. Teresa Woodruff at Northwestern University. In addition, Christina created and preserved genetically altered mouse lines used for research on various human diseases in the Transgenic Facilities of both the University of Wisconsin-Madison and Northwestern University.
Christina obtained her Master of Science degree in Molecular, Cellular, Developmental Biology, and Genetics from the University of Minnesota in August 2007. During graduate school she worked for the Minnesota Department of Health Newborn Screening Laboratory where she performed tests to identify infants with hemoglobinopathies and to screen for metabolic deficiencies. Her thesis research explored the genetics of autism spectrum disorders and parental perceptions of the causes of these disorders.
With research being her main interest, Christina joined the Center for Medical Genetics as a Study Coordinator to aid in the development, design, and implementation of various research studies underway at the Center for Medical Genetics. Currently, she is actively involved in the enrollment and oversight of the PROSE and IMPACT research studies.